Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS)

CNY 37.71

(-1.33%)

Gross Profit Summary of Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

  • Beijing Sun-Novo Pharmaceutical Research Co., Ltd.'s latest annual gross profit in 2023 was 528.34 Million CNY , up 40.72% from previous year.
  • Beijing Sun-Novo Pharmaceutical Research Co., Ltd.'s latest quarterly gross profit in 2024 Q2 was 157.14 Million CNY , up 4.55% from previous quarter.
  • Beijing Sun-Novo Pharmaceutical Research Co., Ltd. reported a annual gross profit of 375.45 Million CNY in annual gross profit 2022, up 42.39% from previous year.
  • Beijing Sun-Novo Pharmaceutical Research Co., Ltd. reported a annual gross profit of 263.68 Million CNY in annual gross profit 2021, up 53.01% from previous year.
  • Beijing Sun-Novo Pharmaceutical Research Co., Ltd. reported a quarterly gross profit of 150.29 Million CNY for 2024 Q1, up 7.22% from previous quarter.
  • Beijing Sun-Novo Pharmaceutical Research Co., Ltd. reported a quarterly gross profit of 162.27 Million CNY for 2024 Q3, up 3.27% from previous quarter.

Annual Gross Profit Chart of Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (2023 - 2017)

Historical Annual Gross Profit of Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (2023 - 2017)

Year Gross Profit Gross Profit Growth
2023 528.34 Million CNY 40.72%
2022 375.45 Million CNY 42.39%
2021 263.68 Million CNY 53.01%
2020 172.33 Million CNY 60.8%
2019 107.16 Million CNY 87.58%
2018 57.13 Million CNY 299.0%
2017 14.31 Million CNY 0.0%

Peer Gross Profit Comparison of Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

Name Gross Profit Gross Profit Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 7.74 Billion CNY 93.178%
Yabao Pharmaceutical Group Co., Ltd 1.66 Billion CNY 68.252%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 13.54 Billion CNY 96.1%
Harbin Pharmaceutical Group Co., Ltd. 3.76 Billion CNY 85.974%
Tasly Pharmaceutical Group Co., Ltd 5.66 Billion CNY 90.665%
Zhejiang Medicine Co., Ltd. 2.52 Billion CNY 79.069%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 3.59 Billion CNY 85.283%
Lionco Pharmaceutical Group Co.,Ltd. 86.95 Million CNY -507.609%
Humanwell Healthcare (Group) Co.,Ltd. 10.65 Billion CNY 95.041%
Ginwa Enterprise (Group) Inc. 431.65 Million CNY -22.402%
Joincare Pharmaceutical Group Industry Co.,Ltd. 9.79 Billion CNY 94.606%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 361.03 Million CNY -46.342%
China Animal Husbandry Industry Co., Ltd. 1.06 Billion CNY 50.554%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 765.77 Million CNY 31.005%
Zhejiang Huahai Pharmaceutical Co., Ltd. 4.83 Billion CNY 89.075%
Shanghai Haoyuan Chemexpress Co., Ltd. 759.03 Million CNY 30.392%
Ningbo Menovo Pharmaceutical Co., Ltd. 342.7 Million CNY -54.17%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 2.07 Billion CNY 74.598%
Chongqing Taiji Industry(Group) Co.,Ltd 7.13 Billion CNY 92.598%
HPGC Renmintongtai Pharmaceutical Corporation 986.11 Million CNY 46.421%
Nanjing Well Pharmaceutical Group Co.,Ltd. 312.86 Million CNY -68.872%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 1.65 Billion CNY 68.079%
Henan Lingrui Pharmaceutical Co., Ltd. 2.42 Billion CNY 78.231%
Shenzhen Chipscreen Biosciences Co., Ltd. 433.54 Million CNY -21.867%
Guizhou Yibai Pharmaceutical Co., Ltd. 1.84 Billion CNY 71.319%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 3.61 Billion CNY 85.374%
Zhongzhu Healthcare Holding Co.,Ltd -114.92 Million CNY 559.726%
Beijing Tongrentang Co., Ltd 8.3 Billion CNY 93.637%
KPC Pharmaceuticals, Inc. 3.33 Billion CNY 84.157%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 735.98 Million CNY 28.212%
North China Pharmaceutical Company Ltd. 3.21 Billion CNY 83.557%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 5.61 Billion CNY 90.591%
Tibet Weixinkang Medicine Co., Ltd. 672.1 Million CNY 21.388%
China National Medicines Corporation Ltd. 3.85 Billion CNY 86.284%
Zhejiang Hisun Pharmaceutical Co., Ltd. 4.18 Billion CNY 87.373%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 1.32 Billion CNY 60.194%
ChengDu ShengNuo Biotec Co.,Ltd. 267.6 Million CNY -97.435%
Dali Pharmaceuticalco.,Ltd 36.29 Million CNY -1355.634%
Changchun BCHT Biotechnology Co. 1.6 Billion CNY 67.005%
Zhejiang Shengda Bio-Pharm Co., Ltd. 74.18 Million CNY -612.211%
Shanghai Jiaoda Onlly Co.,Ltd 62.19 Million CNY -749.487%
Jiang Zhong Pharmaceutical Co.,Ltd 2.74 Billion CNY 80.772%
Mayinglong Pharmaceutical Group Co., LTD. 1.3 Billion CNY 59.584%
Cisen Pharmaceutical Co., Ltd. 2.54 Billion CNY 79.278%
Hunan Warrant Pharmaceutical Co.,Ltd 928.23 Million CNY 43.08%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 19.8 Billion CNY 97.332%
Jianmin Pharmaceutical Group Co.,Ltd. 1.88 Billion CNY 71.918%
Hunan Fangsheng Pharmaceutical Co., Ltd. 1.1 Billion CNY 52.241%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 1.9 Billion CNY 72.235%
Guobang Pharma Ltd. 1.2 Billion CNY 56.293%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 183.75 Million CNY -187.537%
Kangmei Pharmaceutical Co., Ltd. 715.07 Million CNY 26.113%
Shandong Buchang Pharmaceuticals Co., Ltd. 8.7 Billion CNY 93.929%
Zhejiang Starry Pharmaceutical Co.,Ltd. 464.77 Million CNY -13.677%
Henan Taloph Pharmaceutical Stock Co.,Ltd 538.56 Million CNY 1.897%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 1.74 Billion CNY 69.774%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 659.13 Million CNY 19.842%
Shanghai Shyndec Pharmaceutical Co., Ltd. 4.39 Billion CNY 87.976%
Shanghai Yizhong Pharmaceutical Co., Ltd. 336.2 Million CNY -57.153%
Tibet Rhodiola Pharmaceutical Holding Co. 2.94 Billion CNY 82.036%
Sichuan Huiyu Pharmaceutical Co., Ltd. 787.59 Million CNY 32.916%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 431.02 Million CNY -22.578%
CanSino Biologics Inc. -876.01 Million CNY 160.313%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 1.04 Billion CNY 49.392%
Shandong Lukang Pharmaceutical Co.,Ltd. 1.46 Billion CNY 63.831%